Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials (Q28545079)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials	scientific article

Statements

scholarly article

0 references

1 reference

29 May 2020

1 reference

systematic review

1 reference

Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials (English)

0 references

urinary schistosomiasis

1 reference

29 May 2020

schistosomiasis mansoni

1 reference

3 August 2019

1 reference

17 September 2019

1 reference

schistosomiasis

1 reference

based on heuristic

inferred from title

1

object named as

Julien Zwang

0 references

2

object named as

Piero L Olliaro

0 references

language of work or name

0 references

publication date

20 November 2014

8 references

19 February 2019

23 March 2019

20 June 2019

22 June 2019

3 August 2019

4 August 2019

17 September 2019

29 May 2020

PLoS Neglected Tropical Diseases

8 references

19 February 2019

23 March 2019

20 June 2019

22 June 2019

3 August 2019

4 August 2019

17 September 2019

29 May 2020

8

0 references

11

0 references

e3286

0 references

copyright license

Creative Commons Attribution 4.0 International

8 references

Europe PubMed Central

19 February 2019

Europe PubMed Central

23 March 2019

Europe PubMed Central

20 June 2019

Europe PubMed Central

22 June 2019

Europe PubMed Central

3 August 2019

Europe PubMed Central

4 August 2019

Europe PubMed Central

17 September 2019

Europe PubMed Central

29 May 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

Drugs for treating urinary schistosomiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

19 March 2017

Drugs for treating Schistosoma mansoni infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

19 March 2017

Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

19 March 2017

A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

19 March 2017

Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

19 March 2017

A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

19 March 2017

Meta-analysis in clinical trials

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

19 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Praziquantel: a new schistosomicide against Schistosoma haematobium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

19 March 2017

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

7 April 2017

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

7 April 2017

The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

How to interpret figures in reports of clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy of myrrh in the treatment of human Schistosomiasis mansoni

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy of praziquantel against Schistosoma haematobium infection in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

The prevalence and intensity of Schistosoma mansoni infection among residents in two Egyptian villages, at two and twelve months post-treatment with 40 and 60 mg praziquantel per kg body weight at these two villages respectively.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Praziquantel side effects during treatment of Schistosoma mansoni infected pupils in Kibwezi, Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Treatment of schistosomiasis with praziquantel among school children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Impact of drug dosage and brand on bioavailability and efficacy of praziquantel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Assessment of efficacy of praziquantel against Schistosoma mansoni infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Comparison between the efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infections on a sugar estate in Ethiopia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

The effect of praziquantel against Schistosoma mansoni-infections in Botswana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Preliminary clinical trials with praziquantel in Schistosoma japonicum infections in the Philippines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Double-blind studies of tolerance to praziquantel in Japanese patients with Schistosoma japonicum infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

29 September 2017

Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Clinical experience with praziquantel in the treatment of Nigerian patients infected with S. haematobium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Comparative trial of oltipraz versus praziquantel in the treatment of urinary schistosomiasis in the Gabon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Praziquantel and oltipraz: the treatment of schoolchildren infected with Schistosoma mansoni and/or Schistosoma haematobium in Gezira, Sudan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Assessment of side-effects of praziquantel in a trial treatment of Schistosoma haematobium infections in the Afar ethnic group of Ethiopia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Tolerance of two brands of praziquantel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Intestinal schistosomiasis among children in a labour village of Wonji Sugar Estate, Ethiopia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Metrifonate or praziquantel treatment improves physical fitness and appetite of Kenyan schoolboys with Schistosoma haematobium and hookworm infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

3 June 2018

Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003286

21 January 2018

Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003286

21 January 2018

Praziquantel efficacy against schistosomiasis mansoni in schoolchildren in north-west Ethiopia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003286

21 January 2018

Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003286

21 January 2018

Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003286

21 January 2018

Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003286

21 January 2018

Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003286

21 January 2018

Comparative randomised trial of high and conventional doses of praziquantel in the treatment of schistosomiasis mansoni

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0003286

21 January 2018

Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

27 November 2018

Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

27 November 2018

Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

27 November 2018

A comparative trial of praziquantel, metrifonate and niridazole against Schistosoma haematobium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

27 November 2018

Oxamniquine dosage in Malawi.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

27 November 2018

Comparative study of oltipraz versus praziquantel for treatment of schistosomiasis with intestinal manifestation in the Gabon (Schistosoma intercalatum and S. haematobium).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238982

27 November 2018

Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in Northern Senegal

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Praziquantel: a new schistosomicide against Schistosoma mansoni

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Praziquantel in the treatment of mixed S. haematobium and S. mansoni infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind clinical trial comparing praziquantel with oxamniquine in schistosomiasis mansoni

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose finding double-blind clinical trial with praziquantel in schistosomiasis japonica patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survey on the clinical trial results achieved in Brazil comparing praziquantel and oxamniquine in the treatment of mansoni schistosomiasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with schistosomiasis mansoni: a double blind clinical trial comparing praziquantel with oxamniquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiological studies on Schistosoma mansoni infection in the western region of Saudi Arabia using the potassium hydroxide stool digestion technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/25412105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0003286

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28545079&oldid=2087009271"